EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This Employment Agreement (the "Agreement"), dated May 1, 2005, is made by and between Viral Genomix, Inc. (VGX Pharmaceuticals), a Delaware corporation (the "Company"), and with its principal offices at 450 Sentry Parkway East, Blue Bell, PA 19422, and DR. BRYAN BYONGJIN KIM ("Executive"), whose address is 3 Forrest Ct., Mt. Laurel, New Jersey, 08054.
Patent License AgreementPatent License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and VGX Pharmaceuticals, Inc (“VGX”), a corporation organized and existing under the laws of the State of Delaware. This Agreement will become effective on the date on which Penn and VGX have fully executed the Agreement, (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This Employment Agreement (the "Agreement"), dated March 31, 2008, is made by and between VGX Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Dr. J. Joseph Kim ("Executive").
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 10, 2008, between VGXI, Inc. (the “Purchaser”), a Delaware corporation, and VGX Pharmaceuticals, Inc. (the “Company”), a Delaware corporation.
EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus
THIS EMPLOYMENT AGREEMENT (the "Agreement") is made effective the 14th day of November, 2001 between ADViSYS, Inc. ("ADViSYS"), a Delaware corporation, with its place of business at 2700 Research Forest Drive, Suite 180, The Woodlands, Texas, 77381and Ruxandra Draghia-Akli ("Employee") whose residence address is 5215 Starkridge Drive, Houston, Texas, 77035.
VGX PHARMACEUTICALS, INC. WARRANT PURCHASE AGREEMENTWarrant Purchase Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
THESE SECURITIES OF VGX PHARMACEUTICALS, INC. (THE “COMPANY”) ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE BUYER SHOULD BE AWARE THAT HE MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.
BAYLOR COLLEGE OF MEDICINE APPLIED VETERINARY SYSTEMS, INC. LICENSE AGREEMENTLicense Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Texas
This License Agreement (this “Agreement”) is made and entered into on this 25th day of January, 2001 (the “Agreement Date”), by and between Baylor College of Medicine (hereinafter called “BAYLOR”), a Texas non-profit corporation having its principal place of business at One Baylor Plaza, Houston, Texas 77030, and Applied Veterinary Systems, a corporation organized under the laws of Delaware and having a principal place of business at 1709 Dryden Road, Suite 901, Houston, Texas 77030 and its Affiliates (hereinafter, collectively referred to as “AVS”).
AGREEMENT OF LEASE between a Pennsylvania limited partnership, acting by and through its General Partner, AK Real Estate Corp., Landlord and VIRAL GENOMIX, INC. d/b/a VGX PHARMACEUTICALS, TenantAgreement of Lease • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
AGREEMENT OF LEASE made this 21st day of January, 2005, by and between 450 SENTRY PARKWAY ASSOCIATES, a Pennsylvania limited partnership, acting by and through its General Partner, AK Real Estate Corp. (“Landlord”), party of the first part, and VIRAL GENOMIX, INC. d/b/a VGX PHARMACEUTICALS, a Delaware corporation, (“Tenant”), party of the second part.
FORM OF VGX PHARMACEUTICALS NOTE PURCHASE AGREEMENTNote Purchase Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
THIS NOTE PURCHASE AGREEMENT (the “Purchase Agreement”), dated this day of , , is by and between [NAME OF HOLDER]., an individual (the “Buyer”), and VGX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”).
LEASE AGREEMENT VENTURE TECHNOLOGY CENTER XI BUILDING 2700 RESEARCH FOREST DRIVE, SUITE 180 THE WOODLANDS, MONTGOMERY COUNTY, TEXASLease Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Texas
SALES AND MARKETING AGREEMENT BETWEEN VGX PHARMACEUTICALS, INC. (VGX) AND VGX INTERNATIONALSales and Marketing Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This Sales and Marketing Agreement (“AGREEMENT”) is between VGX Pharmaceuticals, Inc. (“VGX”), a Delaware corporation, with offices located at 450 Sentry Parkway, Blue Bell, Pennsylvania 19422, and VGX International (“VI”), a corporation having an address of Jung-Hun Building, #701, 944-1 Daechi 3-Dong, Gangnam-gu, Seoul, Korea.
LICENSE AGREEMENTLicense and Development Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Delaware
EXCLUSIVE LICENSE AGREEMENT BAYLOR COLLEGE OF MEDICINE VGX PHARMACEUTICALS, INC.License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus
This Exclusive License Agreement (hereinafter called “Agreement”), to be effective as of the 9th day of May, 2007 (hereinafter called “Agreement Date”), is by and between Baylor College of Medicine (hereinafter called “BAYLOR”), a Texas nonprofit corporation having its principal place of business at One Baylor Plaza, Houston, Texas 77030, and VGX Pharmaceuticals, Inc., a corporation organized under the laws of Delaware and having a principal place of business at 455 Sentry Parkway, BlueBell, PA, 19422, and its Affiliates (hereinafter, collectively referred to as “VGX”).
ASSIGNMENT OF CONTINGENT PAYMENTSAssignment of Contingent Payments • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Delaware
This Agreement is made this 20th Day of October 2007 (“Effective Date”), by and between VGX Pharmaceuticals, Inc., a Delaware Corporation (hereinafter referred to as “VGXP”), VGX Animal Health, Inc., a Delaware corporation (hereinafter referred to as “VGXAH”), and Ronald O. Bergan and Mary Alice Bergan(hereinafter collectively referred to as “BERGANS”).
CELLECTRA™ DEVICE LICENSE AGREEMENT BETWEEN VGX PHARMACEUTICALS, INC. AND VGX INTERNATIONAL, INC.License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This License Agreement (“AGREEMENT”) is between VGX Pharmaceuticals, Inc. (“VGX”), a Delaware corporation, with offices located at 450 Sentry Parkway East, Blue Bell, Pennsylvania 19422, and VGX International, Inc. (“VI”), a corporation having an address of Jung-Hun Building, #701, 944-1 Daechi 3-Dong, Gangnam-gu, Seoul, Korea.
APPLIED VETERINARY SYSTEMS, INC. VALENTIS, INC. LICENSE AGREEMENTLicense Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Texas
This License Agreement (this “Agreement”) is made and entered into on this 26th day of June, 2000 the (“Effective Date”), by and among Baylor College of Medicine (“BAYLOR”), a Texas non-profit corporation having its principal place of business at One Baylor Plaza, Houston, Texas 77030, Applied Veterinary Systems, Inc., a Delaware corporation having its principal office at 1709 Dryden, Suite 901, Houston, Texas 77030 (hereinafter referred to as “AVS”) and Valentis, Inc., a Delaware corporation having its principal place of business at 863A Mitten Road, Burlingame, California 94010 (hereinafter referred to as “VLTS”).
ContractInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus
THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS. ADDITIONALLY, THE TRANSFER OF THESE SECURITIES IS SUBJECT TO CERTAIN CONDITIONS SPECIFIED IN THIS AGREEMENT DATED AS OF [TODAY’S DATE] BETWEEN VGX PHARMACEUTICALS, INC. (THE “COMPANY”) AND THE SIGNATORY THERETO. NO TRANSFER OF THESE SECURITIES SHALL BE VALID OR EFFECTIVE UNTIL SUCH CONDITIONS HAVE BEEN FULFILLED. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS: (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS; OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL, WHI
COMMERCIAL LICENSE AGREEMENTCommercial License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Delaware
This Agreement is effective as of the latest date of signing below and is by and between Dow Global Technologies Incorporated (“Dow”), a Delaware corporation having its principal offices at 2030 Dow Center, Midland, MI, 48674 USA and VGX Pharmaceuticals, Inc, a Delaware corporation (“VGX”) having a principal place of business at 450 Sentry Parkway, Blue Bell, PA 19422.
NONEXCLUSIVE LICENSE between VGX PHARMACEUTICALS, INC. (VGXP) and VGX ANIMAL HEALTH, INC. (VGXAH)Nonexclusive License • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This NONEXCLUSIVE LICENSE (“NONEXCLUSIVE LICENSE”), made on August 15, 2007 (“EFFECTIVE DATE”), is by and between VGX ANIMAL HEALTH, having a place of business at 2700 Research Forest Drive, The Woodlands, TX 77381 (“VGXAH”), and VGX Pharmaceuticals, Inc., having a place of business at 450 Sentry Parkway East, Blue Bell, PA 19422 (“VGXP”).
LICENSE AGREEMENT BETWEEN VIRAL GENOMIX, INC. (COMPANY) AND THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (PENN)License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This License Agreement (“AGREEMENT”) is between The Trustees of the University of Pennsylvania (“PENN”), a Pennsylvania nonprofit corporation, with offices located at 3700 Market Street, Suite 300, Philadelphia, Pennsylvania 19104-3147, and Viral Genomix, Inc., a corporation organized and existing under the laws of the State of Delaware (“COMPANY”), having a place of business at 3600 Market Street, Suite 100, Philadelphia, PA 19104-2642.
ALLONGEInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus
THIS ALLONGE TO CONVERTIBLE SUBORDINATED PROMISSORY NOTE (this “Allonge”) is made as of November , 2008, between the Borrower and the Holder. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Note.
SUBLEASESublease • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus
THIS SUBLEASE, dated June 10, 2008, with an effective date of June 1, 2008 (the “Effective Date”) is by and between VGX PHARMACEUTICALS, INC., a Delaware corporation “Sublandlord”, and VGXI, INC., a Delaware corporation, hereinafter referred to as “Subtenant”.
ASSET PURCHASE AGREEMENT by and among VGX PHARMACEUTICALS, INC. ADViSYS INC., RONALD O. BERGAN and MARY ALICE BERGAN Dated February 21, 2007Asset Purchase Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 21, 2007, by and among VGX Pharmaceuticals, Inc. (the “Purchaser”), ADViSYS Inc. (the “Company”), a Delaware corporation, and Ronald O. Bergan and Mary Alice Bergan (Mr. and Ms. Bergan together, the “Stockholders”).
ALLONGEInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus
THIS ALLONGE TO CONVERTIBLE SUBORDINATED PROMISSORY NOTE (this “Allonge”) is made as of June , 2008, between the Borrower and the Holder. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Note.
AMENDMENT TO THE CONVERTIBLE SUBORDINATED PROMISSORY NOTEInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus
THIS AMENDMENT is made 19th day of January 2008 by and between VGX Pharmaceuticals, Inc. (previously D.B.A. Viral Genomix, Inc.), a Delaware Corporation, (hereinafter called “Borrower”) and DONG KOOK PHARM, CO. LTD., a Korea Corporation, (hereinafter called “Holder”).
R&D COLLABORATION AND LICENSE AGREEMENT BETWEEN VGX PHARMACEUTICALS, INC. (VGX) AND VGX INTERNATIONALCollaboration and License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This R&D Collaboration and License Agreement (“AGREEMENT”) is between VGX Pharmaceuticals, Inc. (“VGX”), a Delaware corporation, with offices located at 450 Sentry Parkway East, Blue Bell, Pennsylvania 19422, and VGX International Inc. (“VI”), a corporation having an address of Jung-Hun Building, #701, 944-1 Daechi 3-Dong, Gangnam-gu, Seoul, Korea.
ContractInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus • Pennsylvania
THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS. ADDITIONALLY, THE TRANSFER OF THESE SECURITIES IS SUBJECT TO CERTAIN CONDITIONS SPECIFIED IN THE NOTE PURCHASE AGREEMENT DATED AS OF BETWEEN VGX PHARMACEUTICALS, INC. (THE “COMPANY”) AND THE SIGNATORY THERETO. NO TRANSFER OF THESE SECURITIES SHALL BE VALID OR EFFECTIVE UNTIL SUCH CONDITIONS HAVE BEEN FULFILLED. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS: (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS; OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL, WHICH
R&D COLLABORATION AND LICENSE AGREEMENT BETWEEN VGX PHARMACEUTICALS, INC. (VGX) AND VGX INTERNATIONALCollaboration and License Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This R&D Collaboration and License Agreement (“AGREEMENT”) is between VGX Pharmaceuticals, Inc. (“VGX”), a Delaware corporation, with offices located at 450 Sentry Parkway East, Blue Bell, Pennsylvania 19422, and VGX International (“VI”), a corporation having an address of Jung-Hun Building, #701, 944-1 Daechi 3-Dong, Gangnam-gu, Seoul, Korea.
EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Pennsylvania
This Employment Agreement (the "Agreement"), dated August 1, 2005, is made by and between Viral Genomix, Inc. (VGX Pharmaceuticals), a Delaware corporation (the "Company"), and with its principal offices at 450 Sentry Parkway, Blue Bell, PA 19422, and Dr. C. Jo White ("Executive"), whose address is 1007 Stonebridge Road, Lower Gwynedd, PA 19002.
AMENDMENT TO THE CONVERTIBLE SUBORDINATED PROMISSORY NOTEInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus
THIS AMENDMENT is made this 11th day of June 2008 by and between VGX Pharmaceuticals, a Delaware Corporation, (hereinafter called “Borrower”) and Huvitz Co., Ltd. , (hereinafter called “Holder”).
ContractInovio Biomedical Corp • January 23rd, 2009 • Surgical & medical instruments & apparatus • Pennsylvania
THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS. ADDITIONALLY, THE TRANSFER OF THIS NOTE IS SUBJECT TO CERTAIN CONDITIONS SPECIFIED IN THE NOTE PURCHASE AGREEMENT DATED AS OF BETWEEN VGX PHARMACEUTICALS, INC. (THE “COMPANY”) AND THE SIGNATORY THERETO. NO TRANSFER OF THIS NOTE SHALL BE VALID OR EFFECTIVE UNTIL SUCH CONDITIONS HAVE BEEN FULFILLED. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS NOTE TO THE SECRETARY OF THE COMPANY. NEITHER THIS NOTE NOR ANY INTEREST HEREIN MAY BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS: (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS; OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL, WHICH OPINION IS SATISFACTORY TO THE COMPANY, THAT REGISTRAT
